Autotransfusion Devices Market Drivers and Forecasts by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Autotransfusion Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Product and Accessories); Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Others); End User (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers)

  • Report Date : Mar 2022
  • Report Code : TIPRE00006521
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 178

The autotransfusion devices market is expected to grow from US$ 1,000.26 million in 2021 to US$ 1,331.99 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028.

Organ transplantation is a surgical procedure performed in case of organ failure. Usually, organ transplantation is conducted for organs such as the heart, liver, and kidney; however, with rising cases of chronic diseases, transplantation is needed for other organs such as lungs, pancreas, cornea, and vascular tissues. These procedures generally take hours, and there is a lot of blood loss, and autotransfusion is one of the valuable methods to prevent blood loss. According to the United Network for Organ Sharing (UNOS), organ transplants conducted in the US have continuously increased, with over 41,000 transplants performed in 2021. Similarly, according to World Transplant Registry data, Spain accounted for 20% of all organ donations in the EU in 2019 and 6% of worldwide donations. Australia's organ donor rate has improved in recent years, rising to 21.8 donors per million population in 2019.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Autotransfusion Devices Market: Strategic Insights

autotransfusion-systems-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Similarly, Canada has 22.2 donors per million population and is steadily improving, partially attributed to the figure of "Donation Physicians" - intensive care doctors who are responsible for organ donation. According to the World Transplant Registry, China had 5,818 donors in 2019, or 4.1 per million population and India had 715 donors or 0.5 per million population in 2019. On the other hand, Russia had a slightly higher rate of 5.1 donors per million people. The public-private partnership in collaboration with transplant coordinators has made a significant contribution to the improvement of organ transplantation. Both developing and developed countries have seen an increase in organ transplant surgeries. For example, developing countries such as India and Singapore are emerging as medical tourism destinations in Asia Pacific. Countries are progressing in terms of providing better and advanced medical treatments. Thus, the rising need for organ transplantation is among the key factors driving the demand for transplant diagnostics such as autotransfusion devices.

The autotransfusion process involves the reinfusion of the patient's blood. Blood is collected from the peritoneal cavity or thorax region. The process can be carried out before surgery or during and after the surgery using the autotransfusion system. Medical procedures, like joint replacement, spinal surgeries, and cardiac, among others, require autotransfusion. It helps to reduce the risk of infection, and also it eliminates the problems and complications associated with the banking and administration of homologous donor blood. It helps to prevent the transmission of transfusion-related blood-borne diseases in patients.

Market Insights
Technological Developments in Autotransfusion Devices

Autotransfusion devices are usually deployed during long-hour surgeries, such as kidney transplantation, and in cases of emergencies. These surgeries are associated with the chances of excessive blood loss, which makes it difficult to make up the blood loss with new blood, especially in case of rare blood groups. Owing to the ample demand, the key players in the autotransfusion devices market offer advanced and fully automated autotransfusion devices that reduce human interventions. For instance, in April 2021, LivaNova PLC's B-Capta has been approved by the US Food and Drug Administration. During complex paediatric and adult cardiopulmonary bypass surgeries, this device aids in the rapid and accurate monitoring of venous and blood gas parameters. Similarly, in April 2019, BD launched their BD BACTEC quality control media worldwide to help identify contaminated platelet units during transfusions.

Moreover, many companies employed strategic activities such as acquisitions, partnership and others to capture the market. For instance, Medtronics acquired AV Medical Technologies, in October 2019. In December 2019, Getinge purchased Applikon Biotechnology, a global leader in the development and supply of innovative bioreactor systems from the laboratory to the industrial scale. Thus, such advancements are likely to bring new trends in the autotransfusion devices market in the coming years.

Application–Based Insights

Based on application, the autotransfusion devices market is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest share of the market in 2021, while the organ transplantation segment is also estimated to register the highest CAGR in the market during the forecast period.

The autotransfusion devices market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio globally and meet the growing demand. The developments by the companies in the autotransfusion devices market have been characterized as organic and inorganic developments. Various companies are focusing on organic strategies, such as product launch and expansion. Inorganic growth strategies witnessed in the autotransfusion devices market were partnerships and collaborations. These growth strategies have aided the autotransfusion devices market players in the expansion of their businesses and enhanced their geographic presence. Additionally, growth strategies such as acquisitions and partnerships helped in strengthening their customer base and increasing the product portfolio. The companies have maximized their growth with several inorganic strategies to enhance the autotransfusion devices market value and position in the autotransfusion devices market. Organic developments hold 66.67% of the total strategic developments in the autotransfusion devices market. Whereas inorganic strategies account for 33.33% of the growth of the companies.

The autotransfusion devices market has been segmented as follows:

The autotransfusion devices market is segmented based on type, application, and end user. Based on type, the autotransfusion devices market is bifurcated into products and accessories. The autotransfusion devices market, based on application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others.

The autotransfusion devices market, based on end user, is divided into hospitals, specialty clinics, and ambulatory surgical centers.

Autotransfusion Devices Market Regional Insights

The regional trends and factors influencing the Autotransfusion Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Autotransfusion Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

autotransfusion-systems-market-global-geography
  • Get the Regional Specific Data for Autotransfusion Devices Market

Autotransfusion Devices Market Report Scope

Report Attribute Details
Market size in 2021 US$ 1 Billion
Market Size by 2028 US$ 1.33 Billion
Global CAGR (2021 - 2028) 4.2%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Product and Accessories
By Application
  • Cardiac Surgeries
  • Orthopedic Surgeries
  • Organ Transplantation
  • Trauma Procedures
By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic
  • Fresenius SE & Co. KGaA
  • Teleflex Incorporated
  • BD
  • Zimmer Biomet
  • Braile Biomedica
  • Haemonetics Corporation
  • SARSTEDT AG and Co. KG
  • LivaNova PLC

  • Autotransfusion Devices Market Players Density: Understanding Its Impact on Business Dynamics

    The Autotransfusion Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Autotransfusion Devices Market are:

    1. Medtronic
    2. Fresenius SE & Co. KGaA
    3. Teleflex Incorporated
    4. BD
    5. Zimmer Biomet

    Disclaimer: The companies listed above are not ranked in any particular order.


    autotransfusion-systems-market-cagr

    • Get the Autotransfusion Devices Market top key players overview

    Company Profiles in Autotransfusion Devices Market

    • BD
    • Braile Biomedica
    • Fresenius SE & Co. KGaA
    • Haemonetics Corporation
    • LivaNova PLC
    • Medtronic
    • Redax S.p.A.
    • SARSTEDT AG and Co. KG
    • Teleflex Incorporated
    • Zimmer Biomet

    Frequently Asked Questions

    Who are the key players in the autotransfusion devices market?

    The autotransfusion devices market majorly consists of the players such as Medtronic; Fresenius SE & Co. KGaA; Teleflex Incorporated; BD; Zimmer Biomet; Braile Biomedica; Haemonetics Corporation; SARSTEDT AG and Co. KG; LivaNova PLC; Redax S.p.A. among others.

    What is the regional market scenario of autotransfusion devices?

    Global autotransfusion devices market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for autotransfusion devices. The US is estimated to hold the largest share in the autotransfusion devices market during the forecast period. The growth of the market is attributed to factors such as increasing prevalence of cancer in the US, and cancer awareness initiatives undertaken by local governments and global health organizations. In addition, growth involvement of rare blood groups, rising number of transplant procedures and rising prevalence of chronic diseases in the region stimulate the growth of autotransfusion devices market in North America. On the other hand, need for reinfusion of blood, and advancements in healthcare facilities and infrastructure in the Asia Pacific are expected to account for the fastest growth of the region during the coming years.

    Which end-user held the largest share in the autotransfusion devices market?

    The ambulatory surgery centers segment dominated the global autotransfusion devices market and accounted for the largest revenue share of 30.12% in 2021.

    Which application held the largest share in the autotransfusion devices market?

    The organ transplantation segment dominated the global autotransfusion devices market and held the largest revenue share of 3.22% in 2021.

    Which type led the autotransfusion devices market?

    The accessories segment dominated the global autotransfusion devices market and held the largest revenue share of 55.66% in 2021.

    Which product led the autotransfusion devices market?

    The intraoperative autotransfusion systems segment dominated the global autotransfusion devices market and held the largest revenue share of 71.70% in 2021

    What are the driving factors for the autotransfusion devices market across the globe?

    Key factors that are driving the growth of this market are rapid increase in chronic diseases, rise in transplant, and difficulty in obtaining blood of rare groups.

    What are autotransfusion devices?

    The autotransfusion process involves the reinfusion of the patient's blood collected from the peritoneal cavity or thorax region. The process can be accomplished before surgery or during and after the surgery using the autotransfusion system. Medical procedures, such as joint replacement, spinal surgeries, and cardiac surgery require autotransfusion. It helps reduce the risk of infection, and abolishes the problems and complications associated with the banking and administration of homologous donor blood. It also prevents transmission of transfusion-related blood-borne diseases in patients.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Autotransfusion Devices Market

    1. Medtronic
    2. Fresenius SE & Co. KGaA
    3. Teleflex Incorporated
    4. BD
    5. Zimmer Biomet
    6. Braile Biomedica
    7. Haemonetics Corporation
    8. SARSTEDT AG and Co. KG
    9. LivaNova PLC
    10. Redax S.p.A.
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo